DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rallied 1.41% to $219.05 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.14% to 7,637.76 and the Dow Jones Industrial Average rising 0.61% to 51,778.04.
The stock's rise snapped a two-day losing streak.
Biogen Inc. closed 2.99% short of its 52-week high of $225.80, which the company achieved on September 3rd.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.10% to $270.22, Pfizer Inc. $(PFE)$ rose 0.66% to $27.64, and AbbVie Inc. $(ABBV)$ rose 0.58% to $264.02.
Trading volume (836,656) remained 191,018 below its 50-day average volume of 1.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 17, 2026.